Century Therapeutics Inc.
IPSC | NASDAQ
$1.90
+$0.05 (+2.70%)
Sep 22, 2026, 2:21 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 109.16M | 113.34M | 114.13M | 114.9M | 6.59M | 2.69M | 2.04M | 1.37M | 2.24M | 2.49M | 4.56M | 5.86M | 5.2M | 4.68M | 2.45M | 1.06M | n/a | n/a | n/a | n/a |
Cost of Revenue | 25.53M | 52.39M | 49.39M | 49.39M | 26.86M | n/a | n/a | 22.3M | 45.08M | 45.08M | 47.25M | 28.34M | 5.55M | 5.55M | 3.38M | 1.89M | 2.93M | 3.86M | 4.81M | 2.93M | 1.88M | 1.23M |
Gross Profit | -25.53M | -52.39M | 59.78M | 63.95M | 87.27M | 114.9M | 6.59M | -19.61M | -43.04M | -43.71M | -45.02M | -25.85M | -989K | 308K | 1.82M | 2.79M | -475K | -2.81M | -4.81M | -2.93M | -1.88M | -1.23M |
Operating Income | -118.8M | -116.94M | -17.26M | -33.9M | -32.56M | -32.65M | -138.14M | -144.62M | -145.45M | -145.77M | -146.55M | -136.09M | -132.2M | -128.48M | -133.83M | -128.5M | -122.59M | -114.26M | -94.88M | -82.17M | -69.47M | -57.25M |
Interest Income | 6.92M | 6.94M | 7.35M | 8.92M | 10.62M | 12.19M | 13.01M | 13.63M | 13.82M | 13.29M | 12.68M | 9.17M | 5.68M | 2.62M | n/a | n/a | n/a | n/a | 28K | 28K | 28K | 243K |
Pretax Income | -109.86M | -107.85M | -9.64M | -24.7M | -21.51M | -20.16M | -124.78M | -130.75M | -131.64M | -132.8M | -134.79M | -126.18M | -124.77M | -123.4M | -130.84M | -127.34M | -122.63M | -114.93M | -95.78M | -83.16M | -70.22M | -62.25M |
Net Income | -109.79M | -107.78M | -9.57M | -26.48M | -23.28M | -21.95M | -126.57M | -129.89M | -131.39M | -133.47M | -136.67M | -128.96M | -126.99M | -124.68M | -130.93M | -127.44M | -122.7M | -114.99M | -95.82M | -83.16M | -70.22M | -62.25M |
Selling & General & Admin | 20.16M | 22.18M | 24M | 30.8M | 32.32M | 32.82M | 33.16M | 33.99M | 34.62M | 34.55M | 32.54M | 28.81M | 27.88M | 27.91M | 28.47M | 27.91M | 25.08M | 19.98M | 14.42M | 12.95M | 10.03M | 8.9M |
Research & Development | 75.92M | 83.18M | 95.66M | 105.34M | 110.04M | 110.4M | 107.24M | 101.17M | 100.73M | 96.23M | 97.71M | 100M | 99.11M | 100.88M | 97.17M | 93.38M | 87.03M | 81.47M | 75.65M | 66.29M | 57.56M | 47.11M |
Other Expenses | -2.8M | -40.8M | -42.62M | -38.3M | -22.53M | 4.33M | 4.33M | -10.15M | -32.94M | -28.72M | -28.72M | -18.57M | 4.22M | n/a | 10M | 10M | 10M | 10M | n/a | n/a | n/a | n/a |
Operating Expenses | 93.27M | 64.55M | 77.04M | 97.85M | 119.83M | 147.55M | 144.73M | 125M | 102.41M | 102.06M | 101.53M | 110.24M | 131.21M | 128.78M | 135.65M | 131.29M | 122.11M | 111.45M | 90.07M | 79.24M | 67.59M | 56.02M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 136K | 540K | 953K | 1.33M | 1.52M | 1.43M | 1.06M | 1M | 992K | 992K | 1.23M | 964K | 646K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 118.8M | 116.94M | 126.43M | 147.23M | 146.69M | 147.55M | 144.73M | 147.3M | 147.49M | 147.14M | 148.78M | 138.58M | 136.77M | 134.34M | 139.03M | 133.18M | 125.04M | 115.32M | 94.88M | 82.17M | 69.47M | 57.25M |
Income Tax Expense | -68K | -68K | -68K | 1.78M | 1.77M | 1.79M | 1.79M | -854K | -254K | 674K | 1.88M | 2.78M | 2.22M | 1.28M | 91K | 102K | 77K | 59K | 43K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 205.78M | 86.56M | 86.56M | 86.46M | 86.24M | 86.02M | 78.65M | 84.7M | 82.09M | 62.3M | 59.88M | 59.45M | 59.25M | 58.61M | 58.33M | 57.97M | 57.39M | 57.05M | 54.47M | 54.47M | 54.4M | 54.82M |
Shares Outstanding (Diluted) | 205.78M | 86.56M | 86.56M | 86.46M | 86.24M | 86.1M | 78.65M | 84.7M | 82.09M | 62.3M | 59.88M | 59.45M | 59.25M | 58.61M | 58.33M | 57.97M | 57.69M | 57.05M | 54.47M | 54.47M | 54.4M | 54.82M |
EPS (Basic) | -1.04 | -1.25 | -0.11 | -0.35 | -0.32 | -0.32 | -1.66 | -1.86 | -2.04 | -2.22 | -2.30 | -2.18 | -2.16 | -2.14 | -2.27 | -2.25 | -2.20 | -2.09 | -1.76 | -1.61 | -1.44 | -1.38 |
EPS (Diluted) | -1.04 | -1.25 | -0.11 | -0.35 | -0.32 | -0.32 | -1.66 | -1.86 | -2.04 | -2.22 | -2.30 | -2.18 | -2.16 | -2.14 | -2.27 | -2.25 | -2.20 | -2.09 | -1.76 | -1.61 | -1.44 | -1.38 |
EBITDA | -95.09M | -89.9M | 8.52M | -6.77M | -8.47M | -6.86M | -111.47M | -107.56M | -107.9M | -109.15M | -111.79M | -112.58M | -111.96M | -112.04M | -120.65M | -118.75M | -115.74M | -108.71M | -89.69M | -78.43M | -66.39M | -59.39M |
EBIT | -104.8M | -102.79M | -4.58M | -19.64M | -21.51M | -20.16M | -124.78M | -121.1M | -121.49M | -122.51M | -124.1M | -124.72M | -123.52M | -122.03M | -129.64M | -126.23M | -121.49M | -113.73M | -94.51M | -81.87M | -69.21M | -61.56M |
Depreciation & Amortization | 9.71M | 12.88M | 13.1M | 12.87M | 13.04M | 13.3M | 13.3M | 13.54M | 13.59M | 13.36M | 12.31M | 12.14M | 11.56M | 10M | 8.99M | 7.49M | 5.76M | 5.02M | 4.81M | 3.44M | 2.8M | 2.15M |
Add to Watchlist
Select watchlists to add or remove IPSC